Delivery Order SPE2DR25D3104-SPE2DR26FE9CX
Award Date 12/22/25
Potential Completion Date 12/23/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,458.10 on December 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,115.32 to supply Zepbound 2.5 mg/0.5 ml pen injections, with an ultimate completion date of June 9, 2025. This competitive, non-set-aside award was issued on June 6, 2025, under firm fixed price terms. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, representing the type of...
- The Defense Logistics Agency awarded a delivery order valued at $22,101.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price, non-set-aside delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used in the treatment of obesity and...
- The Defense Logistics Agency awarded a delivery order valued at $28,427.31 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections on December 12, 2025, with a completion date of December 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $35,090.09 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist used for weight management, represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $39,008.61 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist used for weight management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,752.01 on October 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management and represents the company's ongoing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $31,081.37 on September 22, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 23, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,909.94 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on December 16, 2025, with completion scheduled for December 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist used for weight management, represents...
- The Defense Logistics Agency awarded a delivery order valued at $42,551.16 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management and represents part of the...